Ear/Nose/Throat
Isis Initiates Phase 1 Study of ISIS-PTP1BRx to Treat Type 2 Diabetes
July 21, 2011 3:41 am | by Bio-Medicine.Org | News | CommentsCARLSBAD, Calif., July 21, 2011 /- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) announced today that it has initiated a Phase 1 clinical study for ISIS-PTP1BRx, an antisense drug for the treatment of type 2 diabetes targeting protein tyrosine phosphatase-1B, PTP-1B. ISIS-PTP1BRx is...
Solos Endoscopy's MammoView® System Proves Crucial to Early Breast Cancer Detection
July 20, 2011 6:43 am | by Bio-Medicine.Org | News | CommentsBOSTON, July 20, 2011 /- Solos Endoscopy, Inc.'s (OTCPK: SNDY) MammoView® instrument line, designed exclusively for breast endoscopy, has become crucial to early breast cancer screening as a method to significantly reduce breast cancer death rates. The Solos MammoView® Breast...
FluMist® (Influenza Vaccine Live, Intranasal) Begins Shipping for 2011-2012 Influenza Season
July 18, 2011 10:51 am | by Bio-Medicine.Org | News | CommentsGAITHERSBURG, Md., July 18, 2011 /- MedImmune announced today that it has begun shipping FluMist® (Influenza Vaccine Live, Intranasal) to influenza vaccine distributors who service health care providers throughout the United States. MedImmune expects to provide approximately...
Panacea Global, Inc. Signs Multi-year Contract Valued at Minimum $8.75 Million for Cancer Detection System with Palmverse Limited
July 12, 2011 6:34 am | by Bio-Medicine.Org | News | CommentsONTARIO, Canada, July 12, 2011 /- Panacea Global, Inc., ("the Company") (OTCQB: PANG), a biopharmaceutical company specializing in blood (protein), serum and tissue tests to diagnose and monitor cancer, today announced that it has signed a multi-year exclusive sales agreement with...
IDEV Technologies Launches Lower Profile SUPERA VERITAS® Stent Delivery System
July 12, 2011 6:34 am | by Bio-Medicine.Org | News | CommentsWEBSTER, Texas, July 12, 2011 /- IDEV Technologies, Incorporated (IDEV), today announced the first procedures in Europe utilizing the new 6 French (6Fr) SUPERA VERITAS® Peripheral Vascular System. The new lower profile delivery system offers physicians more treatment options,...
MedImage Cases™: A New Medical e-Textbook from Projects In Knowledge®
July 12, 2011 6:34 am | by Bio-Medicine.Org | News | CommentsLITTLE FALLS, N.J., July 12, 2011 /- Projects In Knowledge ( www.projectsinknowledge.com ), the leading developer of cutting-edge digital and mobile information tools for busy clinicians, has just launched its newest free electronic medical textbook series: MedImage Cases, offered online...
High Precision Pressure Sensors in CPAP Respiratory Therapy Equipment
July 11, 2011 12:41 pm | by Dr. Adriano Pittarelli | Articles | CommentsContinuous Positive Airway Pressure (CPAP) machines are used to treat sleep apnea, a disorder that restricts breathing, and potentially causes stress to both the heart and circulatory system. Sensortechnics’ HDI and HCE series pressure sensors monitor the instantaneous pressure at the output of the machine and inside the breathing mask, increasing accuracy and sensitivity for individual CPAP users.
Largest Multi-Centre Evaluation of Radioembolization Using Sir-Spheres for Patients With Inoperable Primary Liver Cancer Published in Hepatology
July 7, 2011 3:34 am | by Bio-Medicine.Org | News | CommentsPAMPLONA, Spain, July 7, 2011 /- Results of the multi-centre European Network on Radioembolization with Yttrium-90 Resin Microspheres (ENRY) analysis of the long-term outcomes related to survival and safety of radioembolization using SIR-Spheres in patients with inoperable primary...
Council on Competitiveness Showcases Power of High Performance Computing in Case Study with GNS Healthcare
June 30, 2011 8:34 am | by Bio-Medicine.Org | News | CommentsWASHINGTON, June 30, 2011 /PRNewswire-USNewswire/ -- The Council on Competitiveness, in partnership with the Defense Advanced Research Projects Agency (DARPA), is releasing a case study today highlighting the potential for high performance computing (HPC) to spur innovative solutions for...
A Wristwatch that Monitors Blood Pressure
June 29, 2011 8:32 pm | by Massachusetts Institute of Technology | News | CommentsResearchers hope a device that tracks vital signs around the clock will help patients better control their blood pressure.
The Lancet Publishes Data from Protege, MacroGenics' Phase 3 Clinical Study of Teplizumab in Type 1 Diabetes Patients
June 28, 2011 11:33 am | by Bio-Medicine.Org | News | CommentsROCKVILLE, Md., June 28, 2011 /- MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, announced the publication in The Lancet of results from Protege, a Phase 3 clinical study of...
New Test to Screen for Glaucoma Damage
June 21, 2011 7:45 am | by Bio-Medicine.Org | News | CommentsPINE BROOK, N.J., June 21, 2011 /- A recent paper published in the Journal of Glaucoma shows a new visual evoked potential (VEP) technique to be a fast, objective method to screen for functional damage in glaucomatous eyes. The technique, called short duration transient VEP (SD-tVEP),...
Maroon 5 Lead Singer Adam Levine Raises Awareness of Attention-Deficit/Hyperactivity Disorder in Young Adults and Adults With "Own It"
June 20, 2011 5:39 am | by Bio-Medicine.Org | News | CommentsPHILADELPHIA, June 20, 2011 /- Adam Levine, lead singer of Maroon 5, is helping to raise awareness among young adults and adults about Attention-Deficit/Hyperactivity Disorder (ADHD) through a new national education campaign called "Own It" that launched today. The campaign,...
American Medical Systems Announces Large-Scale, Physician-Led Registry of Penile Implants
June 15, 2011 6:33 am | by Bio-Medicine.Org | News | CommentsMINNETONKA, Minn., June 15, 2011 /- American Medical Systems® (AMS) (NASDAQ: AMMD ), a leading provider of world-class devices and therapies for male and female pelvic health, announced today the commencement of a major global registry of penile prosthetic outcomes. The...
TomoTherapy Shareholders Approve Accuray Acquisition of TomoTherapy
June 9, 2011 9:36 am | by Bio-Medicine.Org | News | CommentsSUNNYVALE, Calif., June 9, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that TomoTherapy shareholders have approved the proposed acquisition of TomoTherapy Incorporated (Nasdaq: TOMO ) by Accuray. More than 98 percent of votes...
New Data On Xeomin® (IncobotulinumtoxinA) To Be Presented At The 15th International Congress Of Parkinson's Disease And Movement Disorders (MDS)
June 8, 2011 11:33 am | by Bio-Medicine.Org | News | CommentsFRANKFURT, Germany, June 8, 2011 /- Merz Pharmaceuticals today announced that new data on Xeomin® (incobotulinumtoxinA), a botulinum toxin type A free from accessory (complexing) proteins, will be presented at the Movement Disorder Society's (MDS) 15th International Congress of...
Otonomy Announces Preclinical Results Supporting Intra-operative Use of OTO-201 for Common Childhood Procedure
June 8, 2011 5:34 am | by Bio-Medicine.Org | News | CommentsSAN DIEGO, June 8, 2011 /- Otonomy, Inc., a developer of innovative therapeutics for diseases and disorders of the ear, today announced positive results for OTO-201, a sustained release gel formulation of the antibiotic ciprofloxacin, in multiple preclinical studies evaluating the...
XTRAC Laser Provides New Hope for Children with Psoriasis
June 8, 2011 5:33 am | by Bio-Medicine.Org | News | CommentsMONTGOMERYVILLE, Pa., June 8, 2011 /- About 20,000 children in the United States under the age of 10 are diagnosed with psoriasis every year. For many, the disease goes beyond painful red, dry patches of scaly, thickened skin; the emotional side-effects are equally life...
Edison Pharmaceuticals to Provide Expanded Access to EPI-743 for Mitochondrial Disease
June 7, 2011 11:32 pm | by Bio-Medicine.Org | News | CommentsMOUNTAIN VIEW, Calif., June 8, 2011 /- Edison Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has allowed an Expanded Access program to provide EPI-743 to seriously ill patients diagnosed with inherited respiratory chain diseases of the mitochondria....
The Premier Basketball League Brings on Key Health Industry Sponsorship for 2012
June 6, 2011 2:35 pm | by Bio-Medicine.Org | News | CommentsCHICAGO, June 6, 2011 /- The Premier Basketball League announced today that Scientific Imaginetics® , the global leader in non-invasive pain relief technology, has come on board as a corporate sponsor for the 2012 PBL season. Scientific Imaginetics' TMR® technology is a...
NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meetin...
June 4, 2011 11:34 am | by Bio-Medicine.Org | News | CommentsCHICAGO and SAN FRANCISCO, June 4, 2011 /- Nektar Therapeutics (Nasdaq: NKTR ) today announced positive results from a Phase 2 clinical study evaluating single-agent NKTR-102 as a second- and third-line treatment in patients with metastatic breast cancer during the 2011 American Society...
Wake Forest Baptist Medical Center and Cornerstone Pharmaceuticals Present Interim Data From Phase I Trial of CPI-613 in Acute Myeloid Leukemia
June 3, 2011 6:36 am | by Bio-Medicine.Org | News | CommentsCHICAGO, June 3, 2011 /- Cornerstone Pharmaceuticals and Wake Forest Baptist Medical Center today announced key findings from a Phase I clinical trial of Cornerstone's first-in-class cancer metabolism inhibitor drug, CPI-613 in Acute Myeloid Leukemia (AML). Data will be presented at the...
Biocept and Academic Collaborators to Present Poster at ASCO on Circulating Tumor Cells (CTCs)
June 2, 2011 1:33 pm | by Bio-Medicine.Org | News | CommentsSAN DIEGO, June 2, 2011 /- Biocept, Inc. today reported that its scientists and academic collaborators will present a poster at the 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO) taking place in Chicago, Illinois June 3-7. The poster presentation is based on...
At SIIM 2011 Siemens Showcases Imaging IT Solutions for Driving Greater Value in Radiology and Other Specialties
June 2, 2011 6:34 am | by Bio-Medicine.Org | News | CommentsWASHINGTON, June 2, 2011 /- Siemens Healthcare (NYSE: SI) will showcase its portfolio of imaging information technology (IT) and workflow management solutions at the Society for Imaging Informatics in Medicine (SIIM) 2011 Annual Meeting from June 2-5, 2011, (booth 825) in the Gaylord...
CSL Behring Receives EU Orphan Drug Designations for rVIIa-FP for Hemophilia A and B Treatment
May 31, 2011 6:33 am | by Bio-Medicine.Org | News | CommentsKING OF PRUSSIA, Pa., May 31, 2011 /- CSL Behring announced today that it has been granted Orphan Drug Designations (ODD) by the European Commission for the development of its recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP), a novel therapy to treat...
